Pepgen to participate in upcoming investor conferences

Boston--(business wire)--pepgen inc. (nasdaq: pepg), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today announced that management will participate in the following upcoming investor conferences: guggenheim's inaugural healthcare innovation conference (boston, ma) monday, november 11, 2024 at 1:00 p.m. et, fireside chat stifel 2024 healthcare confere.
PEPG Ratings Summary
PEPG Quant Ranking